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Pathophysiology of the kidney in rats with Heymann nephritis
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Pathophysiology of the kidney in rats with Heymann nephritis. Alter-
ations in kidney function were assessed early in the course of Heymann
nephritis that was induced in rats by immunization with FxIA, an
extract prepared from rat kidney cortex. Whole kidney and single
nephron function were evaluated by clearance and micropuncture
techniques. Kidney function was studied in stage 1 of Heymann
nephritis, before the onset of proteinuria, and in stage 2, when antibod-
ies are deposited along the brush border of proximal tubules. Although
overall kidney function was similar in rats in stage 1 and normal
controls, glucose reabsorption was somewhat depressed in the first part
of the proximal convoluted tubule in stage I. Both whole kidney and
single nephron glomerular filtration rates were depressed in stage 2.
Proteinuria in stage 2 was characterized by an increased albumin
sieving coefficient, which resulted in an elevated excretion of albumin.
Furthermore, several proximal tubule functions (glucose and fluid
reabsorption and PAH extraction) were substantially depressed in stage
2. These findings demonstrate that immunological injury to the proximal
tubules in stage 2 of Heymann nephritis produces a significant impair-
ment of proximal function.
Physiopathologie du rein chez des rats atteints de néphrite de
Ileymann. Les alterations de Ia fonction rénale ont ete mesurées
précocément au cours d'une néphrite de Heymann, qui a été induite
chez des rats par immunisation avec FxIA, un extrait prepare a partir
de cortex de rein de rat. La fonction rénale globale et nephronique
individuelle a été évaluée par des techniques de clearance et de
microponction. La fonction rénale a été dtudiée au stade 1 de Ia ndphrite
de Heymann, avant l'apparition de Ia protéinurie, et au stade 2 lorsque
les anticorps étaient dCposés le long de Ia bordure en brosse des tubules
proximaux. Bien que Ia fonction rCnale globale soit identique chez des
rats au stade I et chez les contrôles normaux, Ia reabsorption de glucose
était quelque peu diminude dans Ia premiere partie du tubule contourné
proximal au stade I. Les debits de filtration glomérulaire du rein entier
et nephronique individuel étaient diminués au stade 2. La proteinurie,
au stade 2, était caractérisée par une augmentation du coefficient de
filtration de l'albumine, qui aboutissait a une élévation de l'excrétion
d'albumine. Dc plus, les fonctions tubulaires proximales (reabsorption
de glucose et de liquides et extraction du PAH) étaient substantielle-
ment diminuCes au stade 2. Ces résultats démontrent qu'une atteinte
immunologique des tubules proximaux au stade 2 de Ia néphrite de
Heymann induit une alteration significative de Ia fonction proximale.
Heymann nephritis, an autoimmune disease, can be produced in
some strains of rat by immunization with an extract prepared from rat
kidney cortex [1, 2]. Autoantibodies in the sera of rats with Heymann
nephritis are directed against antigens present on epithelial cells of the
glomerular capillary wall and in the brush border of proximal tubules
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[3—5]. Deposition of autoantibodies in the glomerulus leads to a
classical membranous nephropathy. Increased permeability to mac-
romolecules, resulting from the membranous lesion in glomeruli,
allows circulating anti-brush border antibodies to gain access to the
proximal tubule lumen, producing severe damage to the integrity of
the tubule epithelium [6, 7]. However, later in the course of
Heymann nephritis, with waning of the anti-brush border response,
deposits of antibodies disappear from the proximal tubules and the
epithelium resumes a nearly normal appearance [6]. Although
glomemlar immune deposits may partially disintegrate late in
Heymann nephritis, heavy proteinuria persists [8].
Previous studies of kidney pathophysiology have focused on
alterations in glomerular function that occur late in the course
of Heymann nephritis [9, 10]. The possibility of impaired
proximal tubule functions in rats with Heymann nephritis has
not been previously investigated in detail, although decreased
para-amino-hippuric acid extraction [9] and an increased glu-
cose excretion [8] have been observed in animals chronically ill
with Heymann nephritis.
In this study we investigated kidney pathophysiology in the
first two of the four stages of Heymann nephritis that charac-
terize the natural course of the disease [6]. Kidney function,
estimated by assays of serum, urine, and tubule fluid, was
evaluated before the onset of proteinuria (stage 1) and in the
phase of increasing proteinuria (stage 2) when antibodies are
deposited along the brush border of proximal tubules. Special
emphasis was placed on the measurement of proximal tubule
functions. Our findings demonstrate that immunological injury
to the proximal tubules in stage 2 of Heymann nephritis is
accompanied by a significant impairment of reabsorptive and
secretory processes in proximal tubules.
Methods
Animals
Female LEW rats, purchased from Charles River Breeding
Laboratories (Wilmington, Massachusetts, USA) were immu-
nized with FxlA [11] at the age of 2.5 months. Stage 1 of
Heymann nephritis lasts 6 to 8 weeks from the time of the initial
FxlA immunization. Animals in stage 1 were, therefore, 2.5 to
4.5 months old. Rats in stage 2, which begins with the onset of
proteinuria and lasts approximately 6 weeks, were 4.5 to 6
months old. Normal rats, studied as controls, were 3 to 6
months old. The physiological parameters measured in this
study were not observed to vary with age in normal rats. The
body wt of animals in all three groups ranged from 200 to 250 g.
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Antigen preparation
Frozen rat kidneys were purchased from Pel-Freeze Biolog-
icals (Rogers, Arizona, USA). The antigen fraction used for
immunization, Fx1A, was prepared according to the method
described by Edgington, Glassock, and Dixon [11].
Immunization protocol
Rats were immunized in the hind footpads with 0.3 ml of an
emulsion containing 10.0 mg of Fx1A, 0.5 mg of
Mycobacterium butyricum (Difco Laboratories, Detroit, Mich-
igan, USA), 0.15 ml of saline and 0.15 ml of complete Freund's
adjuvant (Difco Laboratories, Detroit, Michigan, USA).
Twenty-eight days later, a second identical injection was ad-
ministered in the front feet. Significant proteinuria (> 50 mg124
hr) usually developed within 6 to 8 weeks of the initial immu-
nization. A control group receiving only complete Freund's
adjuvant was omitted, as previous studies have shown no effect
of this agent on kidney function 1$, 121.
Kidney function
Two days before micropuncture experiments, urine was
collected from animals kept in metabolism cages for 16 hr with
free access to water, but deprived of food. Blood samples were
obtained from the tail vein at the end of the collection period.
Protein excretion, creatinine excretion, plasma protein compo-
sition, and plasma creatinine concentration were determined
from these samples.
Micropuncture studies
Animals were anesthetized by intraperitoneal injection of
mactin (Promonta) (10 mgIlOO g body wt) and prepared for
micropuncture by conventional techniques [13]. An intravenous
infusion of isotonic saline solution was administered (0.02
ml/min x 100 g body wt). The infusion contained 4 g/dl of
synthetic inulin (polyfructosan, Laevosan) and 0.1 g/dl of
para-aminohippuric acid (PAH) for the measurement of single
and total glomerular filtration rate (snGFR and GFR) and PAH
clearance (CPAH), respectively. Urine was collected by a blad-
der catheter (PE 160 tubing) that led into a weighed test tube.
Tail blood samples were taken at the beginning and end of each
urine collection period. Blood pressure, when monitored, was
recorded continuously from the carotid or femoral artery by
using a Stathem P23GC tranducer (Gould Inc., Oxnard, Cali-
fornia, USA) and a Grass model 79 Polygraph (Grass Instru-
ment Co., Quincy, Massachusetts, USA).
Four types of micropuncture experiments were performed:
(1) Determination of snGFR. Samples of tubule fluid were
collected quantitatively from random sites in proximal tubules
after injection of a castor oil block. Collection time was 3 to 7
mm under conditions of slight negative pressure. Sample vol-
ume was determined immediately by its measured length in a
constant bore capillary tube, and snGFR was calculated as
collected volume per miii times the tubule fluid to plasma inulin
ratio, (TFIP)1111. Four to six determinations of snGFR were
made during each of two measurements of GFR per experi-
ment. For end-proximal samples, puncture sites were selected
near the efferent star. In some experiments, intravenous injec-
tion of a bolus (0.05 ml of a 5 percent solution) of FDCG (Food
Dye and Colouring Green N. 3, Keystone Aniline and Chemical
Co., Chicago, Illinois, USA) was used to identify end proximal
sites [14]. The end-proximal location was always verified by
following the course of injected oil droplets. The appearance of
more than one loop before the final disappearance of the drop
disqualified the sample as end-proximal. When the dye was
used in rats in stage 1 or stage 2 of Heymann nephritis, no
staining was observed in the kidney interstitium that might have
indicated leakage of dye from the tubule lumen.
(2) Determination of tubule fluid protein concentration. Free
flow samples (30 to 60 nI) were collected from random sites in
proximal tubules. Tubule fluid was also analyzed for inulin
when sample size permitted. Collection time ranged from 5 to
10 mm.
(3) Determination of tubule fluid glucose concentration. Free
flow samples (50 to 100 nI) were collected from random sites in
proximal tubules. Tubule fluid was also analyzed for inulin
when sample size permitted. Collection time ranged from 10 to
20 mm. At the conclusion of most experiments, a latex cast was
made of the tubule to determine the site of puncture [15]. The
(TF/P)11111 ratio and the latex cast were both used to determine
the approximate site of puncture.
(4) Determination of renal extraction of PAH and tetraeth-
ylammonium (TEA). The extraction of PAH, an organic anion,
and TEA, an organic cation, was determined by sampling from
a catheter in the renal vein. The peritoneal cavity was opened
by an abdominal incision to expose the left ovarian and renal
vein. A catheter (PE 50 with tapered tip) was introduced into
the left ovarian vein and threaded until the tip protruded into
the lumen of the renal vein, according to the method described
by Jaenike [16]. The left adrenal vein was tied and blood was
collected from the renal vein catheter by dripping into a
heparinized hematocrit tube. Arterial blood samples were taken
from a catheter (PE 50) placed in the right femoral artery.
3H-TEA bromide (New England Nuclear Corp., sp. act. 1.0
mCiI2.3 mg) was added to the infusions to maintain a plasma
concentration of 3H-TEA of 0.03 tCi/ml.
Analytical methods
Urine and plasma inulin concentrations were measured by
the anthrone method of Fuhr, Kaczmarczyk, and Kruttgen [17];
tubule fluid inulin concentration was measured by a
micromodification of the same method [18]. Color development
in the microsamples was read in a spectrophotometer adapted
for a 3 l cuvette. PAH concentrations in urine and plasma
were analyzed according to the method of Brun [19]. A Packard
(Tri-Carb) liquid scintillation counter (Model 4640) was used to
measure 3H-TEA. The scintillation fluid consisted of 3 ml of
Hydrofluor (National Diagnostics, Inc.) to which was added 10
to 20 l of plasma or urine. 3H quench standards were used to
determine counting efficiency.
The glucose concentration in urine and plasma was measured
by the hexokinase method [20] with the use of commercial
reagents (Boehringer-Mannheim). Tubule fluid glucose was
determined by a micromodification of the hexokinase method
[211. The creatinine concentration in plasma and urine was
analyzed after absorption and elution from Lloyd's reagent [221.
Sodium concentration in plasma and urine, and sodium and
potassium content in kidney tissue was measured by flame
photometry (Klina Flame, Beckman Instruments). At the con-
clusion of the experiments, both kidneys were decapsulated,
bisected, blotted on wet gauze, and weighed. In the animals in
which the sodium and potassium content of the kidney would be
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Table 1. Aspects of protein excretion in early Heymann nephritis
UprotV UaibV Urine protein
composition
% HMW
.Proximal
TF
mg/dl
.
overnight
mg/24 hr X
.
micropuncture
100 g body wt
.
overnight
mg/24 hr x
•
micropuncture
100 g body wt % LMW % Albumin
Control 0.96 0.15 5.05 1.07 0.27 0.05 2.04 0.53 34 2 30 3 37 2 3.3 0.4
(18) (6) (12) (6) (12) (12) (12) (35)
HN 2.69 0.58 5.21 1.42 1.65 0.06 2.13 0.55 34 3 34 4 32 3 3.1 0.5
Stage 1 (23) (6) (13) (6) (13) (13) (13) (27)
HN 146 lI 204 32 81.3 9.6a 87 18 14 3° 58 4 29 2 22.0 l.9a
Stage 2 (28) (5) (15) (5) (15) (IS) (15) (38)
Numbers of animals or tubule fluid samples (TFalb) used to determine each mean value are indicated in parentheses. Urine protein composition
was analyzed in samples collected overnight. Protein composition was determined from overnight collections.
Significantly different from control and HN Stage 1 at P < 0.05.
Abbreviations are: UprotV, protein excretion; UalbV, albumin excretion; LMW, molecular weight < albumin; 11MW, molecular weight >
albumin; TF, tubule fluid.
determined, the animal received an intravenous injection of
sodium heparin (100 IU) a few minutes before the kidneys were
removed. This procedure was to minimize the residual blood
volume remaining in the kidney [23]. The left kidney was dried
to constant weight in an oven at 90°C for 48 hr. The right kidney
was frozen in liquid nitrogen and processed for evaluation by
immunofluorescence microscopy. The water content of the left
kidney was determined from the difference between wet and
dry weights. The tissue was digested by the method of
Zamlauski and Cohen [241, and then analyzed for sodium and
potassium content.
Total protein concentration in urine was determined by the
method of Lowry et al [25] after trichloroacetic acid precipita-
tion. This information was used to determine the proper dilution
for urine analysis by electrophoresis. The gel electrophoresis
procedures used for separation and quantification of proteins in
plasma and urine and for analysis of protein in proximal tubule
fluid have been described elsewhere [26—281. Systematic colloid
osmotic pressure (COP) was calculated from the Pappenheimer-
Renkin equations [29] using values for albumin and high molec-
ular weight protein (HMW) as determined by electrophoresis
analysis. All values are given as the means SE. Student's t test
was used for statistical analysis [30]. There was no significant
difference (P < 0.05) between normal rats and rats in stage 1 for
any measurement. Therefore, we also used Student's t test to
compare rats in stage 2 with normal rats, with stage 1, and with
normals and stage 1 combined.
Immunopathology
Rats were sacrificed at the conclusion of micropuncture
experiments. Kidney tissue samples obtained at the time of
death were processed for evaluation by immunofluorescence
and light microscopy.
Immunofluorescence tests
Direct immunofluorescence tests were performed on frozen
sections of rat kidney to determine the sites of deposition of
immune reactants. Details of the procedures used for im-
munofluorescence tests in our laboratory have been published
elsewhere [31, 321. FITC-conjugated antisera to rat immuno-
globulins were purchased from Cappel Laboratories,
Cochranville, Pennsylvania, USA.
Histology
Kidney tissue samples were fixed by immersion in 10%
buffered formalin and embedded in paraffin. Sections 4 s thick
were stained with hematoxylin-eosin and periodic acid Schiff
reagent for examination by light microscopy.
Determination of the stages of Heymann nephritis
To monitor the course of Heymann nephritis, serum and
urine samples were collected and analyzed weekly. Anti-brush
border antibody titers were measured by means of indirect
immunofluorescence tests [6]. Urinary protein concentration
was determined with the biuret test. The following criteria,
which have been described previously [61, were used to distin-
guish the stages of Heymann nephritis.
Stage 1: Low, but increasing titers of circulating antibodies to
brush border of proximal tubules. Weak granular immune
deposits in glomerular basement membrane, no immune depos-
its in brush border of proximal tubules, normal proximal tubule
morphology, no proteinuria.
Stage 2: High titers of circulating anti-brush border antibod-
ies. Heavy granular immune deposits in glomerular basement
membrane, heavy deposits of immunoglobulin in brush border
of proximal tubules, damaged proximal tubule epithelium,
proteinuria of 1 to 6 weeks duration.
Results
Stage 1 of Heymann nephritis
Total protein and albumin excretions calculated from overnight
urine collections or from urine collected during micropuncture ex-
periments were within normal liniits (Table 1). Urinary protein
composition remained unchanged. The urinary excretion rates for
protein were higher during micropuncture experiments than when
measured during overnight urine collections. This was also true for
animals in the control group and has been noted before [12]. Mean
proximal convoluted tubule fluid albumin concentration in stage 1
was similar to that in controls [Table 1, Fig. 1]. There was no
evidence of increasing TFb with distance along the proximal
convoluted tubule in either group. If one assumes that excessive
albumin reabsorption does not take place in the initial and inaccessi-
ble portion of the proximal convoluted tubule [26], filtrate concentra-
tion must be similar to the mean concentration (3 mg/dl). This
estimate of filtrate concentration was used to calculate the filtered
load of albumin. From that, the fractional excretion of albumin was
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Table 2. Kidney function in early Heymann nephritis
V
id/mm
x g kidney wt (U/P)JN
CIN
mi/mm X g
kidney wt
SNGFRC
ni/mm X g
kidney WI
RPFb
mi/mm x g
kidney wt FF
FEGIUCOSa
mEq/24 hr
x g kidney wI
FENU+
%
MAP
mm Hg
Control 4.0 0.3 197 12 0.75 0.06 29.9 4.7 2.82 0,23 0.30 0.02 0.07 0.01 0.14 0.04 95 5
(24) (24) (29) (37) (26) (26) (11) (11) (11)
HN 4.5 0.3 186 11 0.79 0.06 26.1 6.6 2.75 0.19 0.29 0.01 0.23 0.10 0.23 0.06 104 4
Stage 1 (30) (30) (30) (43) (29) (29) (17) (17) (17)
HN 4.2 0.3 128 9 0.48 0.030 18.0 0.90 1.96 0.200 0.30 0.03 7.62 3.Ola 0.21 0.05 107 3
Stage 2 (38) (38) (38) (72) (28) (28) (23) (23) (23)
Number of animals or tubule fluid samples (SNGFR) used to determine each value are indicated in parentheses. Filtration fraction was calculated
by dividing the CIN by the RPF.
a Significantly different from control and HN Stage 1 at P < 0.05.
b RPF was calculated by dividing the CPAH for each experiment by the mean extraction ratio of PAH determined for each group.
C Values for SNGFR calculated per kidney for control (N = 6), HN Stage 1 (N = 10) and 2 (N = 13) are 26.9 5.3, 23.9 2.6, and 17.9 2.0
ni/mm g kidney wt, respectively.
Abbreviations are: V, urine flow rate; U, urine concentration; P. plasma concentration; C, clearance; IN, inulin; SNGFR, single nephron
filtration rate; RPF, renal plasma flow; FF, filtration fraction; FE, fractional excretion; MAP, mean arterial blood pressure.
determined to be 7.7% in the control group and 8.1% in animals in
stage 1. The accompanying reabsorption rate was 22.8 and 22.5
xg/min x g kidney wt for controls and animals in stage 1, respec-
tively.
Total kidney GFR (C1011) in renal plasma flow in rats in stage
1 were similar to control values (Table 2). Single nephron GFR
was also comparable to that seen in animals in the control group
(Fig. 2). Consequently, the filtration fraction remained
unchanged.
Proximal tubule function remained unchanged in stage 1
except as noted below. Normal values for EPAH, ETEA, and
proximal (TF/P)111 as a measure of fluid reabsorption (Table 3)
were observed. Overall glucose reabsorption in the proximal
convoluted tubule (Fig. 3) was similar in rats in stage I and
controls. However, there was evidence that in the first part of
the proximal tubule, which is inaccessible for micropuncture
sampling, glucose reabsorption was depressed in stage 1 of
Heymann nephritis. Decreased glucose reabsorption could not
be explained by an elevation of either the plasma glucose
concentration (Table 4) or the glomerular filtration rate (Table
2). Fractional glucose excretion (Table 2) and urinary glucose
concentration and excretion were not significantly different
when rats in stage 1 were compared to the control group
(Ugiucose control — 16 3 mg/dl, stage 1 — 54 21 mg/dl;
Ugiucose V control — 0.0005 0.0001 mg/mm x g kidney wt,
stage 1 — 0.0015 0.001 mg/mm x g kidney wt). Fractional
(Table 1) and absolute sodium reabsorption (control — 0.27
0.009 mEq/24 hr x g kidney wt; stage I — 0.47 0.18 mEq/24
hr x g kidney wt) were also within normal limits in stage 1.
The concentration of all plasma constituents (Table 4) was
similar to control values. Analysis of kidney tissue (Table 5) did
not reveal any deviation from normal in stage I of Heymann
nephritis.
Observations, made by immunofluorescence and light mi-
croscopy, of samples of kidney tissue obtained from each rat at
the conclusion of the micropuncture experiment confirmed that
60 each was in stage I of Heymann nephritis. Fine, granular
deposits of immunoglobulin were present along the glomerular
capillary wall. In some cases, focal granular deposits were also
seen along the basement membrane of proximal tubules. No
immunoglobulin deposits were noted on the brush border of
Control
(35)
100
50
100
50
100
0,C0
2:
5)
CO00
0
Stage 1
(27)
50
Stage 2
(38)
20 40
Proximal TF albumin,
mg/dI
Fig. 1. Frequency distribution of albumin concentration in proximal
convoluted tubule in early HN.
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Fig. 2. Frequency distribution of single nephron filtration rate in early
HN.
proximal tubules. The morphology of proximal tubules ap-
peared normal.
Stage 2 of Heymann nephritis
Protein excretion was markedly increased in stage 2 (Table
1). Absolute excretion increased for proteins in all size catego-
ries [albumin, HMW (MW > albumin), LMW (MW < albu-
min)]. However, the fractional contribution of albumin to total
protein excretion was significantly increased. The resulting
albuminuria is consistent with the increase in proximal tubule
fluid albumin concentration (Table 1, Fig. 1). Capsule fluid
albumin concentration and the sieving coefficient could be
estimated since, with protein excretion of this magnitude,
reabsorption could be considered to be negligible [33]. Using
simultaneous TFalbumin and (TFIP)111 ratios, a mean capsule
fluid (CF) albumin concentration of 13.7 mgldl (N = 28) was
derived [33]. When urine albumin concentrations were substi-
tuted for tubule fluid albumin concentrations, a similar value
(11.1 mgldl) was obtained. The corresponding sieving coeffi-
cient [(CF/P)albumin] S 70 X 10 (N 5).
Both whole kidney and single nephron filtration rate were
decreased in animals in stage 2 (Table 2, Fig. 2). As a similar
decrease was noted in renal plasma flow, the filtration fraction
remained normal. The depression of SNGFR seemed to be a
homogeneous reponse to superficial nephrons within a given
kidney since the variation of values within a single kidney was
not greater than that seen in normal animals (Fig. 4). This
depression can account completely for the decrease in whole
kidney filtration rate, which means there is no reason to assume
that nephrons have been lost.
Proximal tubule function was also depressed in stage 2 of
Heymann nephritis. The extraction ratio of PAH was signifi-
cantly decreased in stage 2 (Table 3), which resulted in a
decrease in PAH clearance. Although the extraction of TEA
was lower in stage 2 than in controls and in stage 1, the decrease
was smaller than the decrease in PAH extraction and not
statistically significant (Table 3). Accordingly, the clearance of
TEA was not significantly reduced in stage 2. Late proximal
was decreased in stage 2, indicating a decrease in
proximal tubule fluid reabsorption (Table 3). Further evidence
of impaired proximal tubule function was observed when tubule
glucose handling was studied. TFgiucose concentration was
markedly elevated in animals in stage 2 (Fig. 3) in the presence
of normal plasma glucose levels (Table 4). Thirty-three percent
of the filtered glucose remained at the end of the proximal
convoluted tubule. This compared with 12 and 10% in controls
and in stage 1, respectively. Overall fractional excretion was
over 7% compared to essentially complete reabsorption in
normal and in animals in stage 1 (Table 2). Fractional excretion
of sodium was not elevated in stage 2 (Table 2).
The plasma protein composition reflected the proteinuria
characteristic of stage 2. Total protein and albumin concentra-
tion and colloid osmotic pressure were significantly decreased.
Obvious fluid retention (ascites) did not accompany these other
signs of the nephrotic syndrome. Lipemia was not observed
routinely.
The kidneys from rats in stage 2 exhibited a significant
increase in wet wt (Table 5). In addition, the ratio of the kidney
wet wt to total body wt also increased. The increase in kidney
wet wt resulted from a 2% increase in kidney water content and
a 22% increase in kidney dry wt. The increase in kidney wt was
accompanied by an increase in both the sodium and potassium
content of the kidney (Table 5).
The immunopathology observed in rats in stage 2 was com-
parable to that previously documented [6]. Granular immuno-
globulin deposition occurred along the glomerular capillary
wall. Antibody deposits were also observed along the brush
borders of proximal tubules. Microvilli were lost from the
luminal membrane of proximal tubule cells; and some reduction
of basolateral invaginations and increased epithelial cell prolif-
eration were noted.
Discussion
Other functional studies of Heymann nephritis have all been
done in late stages of the disease [9, 10, 34, 35]. The various
signs of kidney dysfunction observed in rats with Heymann
nephritis were those associated with chronic glomerulonephri-
tis; impairment of tubular function was not a prominent feature.
The present study focuses on the early manifestations of
Heymann nephritis. From the observations described here, we
conclude that immunlogically mediated injury to the kidney
early in the course of Heymann nephritis produces functional
alterations in tubules as well as glomeruli.
Several proximal tubule functions were found to be substan-
tially impaired in rats in stage 2 of Heymann nephritis. Fluid
and glucose reabsorption were inhibited and organic anion
secretion was significantly depressed. In an earlier report, a
similar decrease in organic anion transport was documented
60
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Table 3. Proximal tubule dysfunction in early Heymann nephritis
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PAH TEA
CC
mi/mm )< g kidney mi/mm x g kidney (TF/P)1
ER wt ER wt late PCT
Control 0.75 0.03 2.12 0.17 0.79 0.03 1.76 0.30 1.89 0.11
(5) (26) (4) (4) (28)
HN 0.70 0.02 1.93 0.14 0.79 0.02 2.02 0.09 1.92 0.09
Stage 1 (7) (29) (4) (4) (38)
HN 0.56 009b 1.10 0.lla 0.69 0.07 1.52 0.10 1.41 0.07
Stage 2 (10) (28) (8) (8) (42)
Number of animals or tubule fluid samples used to determine each value are indicated in parentheses.
a Significantly different from control and HN Stage I at P < 0.05.
b Significantly different from combined Control and HN Stage 1 data at P < 0.05.
Abbreviations are: PAH, para-aminohippuric acid; TEA, tetraethylammonium; ER, extraction ratio; C, clearance; TF, tubule fluid; P, plasma
concentration; PCT, proximal convoluted tubule.
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.
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Early Middle Late
Proximal convoluted tubule
Fig. 3. Glucose transport in proximal convoluted tubule in early HN.
*significantly different from control at P < 0.05. (TF/P)0iuco,eI
(TF/P)111 = %of filtered load of glucose remaining in tubule. Early =
firstaccessible convolutions. Middle = intermediate convolutions. Late
= late surface convolutions before Henle's loop. Symbols are:
Stage 2; A A, Stage 1; andS •, Control.
late in the course of Heymann nephritis. However, that defect
in transport was not associated with a depression of fractional
proximal tubule fluid reabsorption [9, 101. In another report,
decreased fractional proximal convoluted tubule fluid reabsorp-
tion was described in stages 2 and 3 of Heymann nephritis [35J.
However, those experiments were performed under conditions
of extreme volume expansion that depress reabsorption in
normal animals and are, therefore, difficult to interpret.
Stage 2
(13)
0 155 10
Standard deviation
of SNGFR
within a single kidney,
ni/mm x g kidney wt
Fig. 4. Frequency histogram depicting the range of standard deviation
in snGFR values calculated from each offive controls, seven animals in
stage 1 and 13 animals in stage 2 of Heymann nephritis.
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Table 4. Plasma composition in early Heymann nephritis
Total
protein
g/dl
Albumin
gIdI
Albumin!
HMW
COP plasma
mm Hg
COPL efferent
arteriole
mm Hg
Glucose
gidi
Hematocrit
%
Creatinine
mg/d!
Sodium
mEqlliter
Control 7.41 0.23 3.64 0.09 1.08 0.04 21.1 0.6 28.7 1.4 126 6 49 1 0.44 0.04 147 1
(21) (21) (21) (11) (20) (5) (21) (13) (13)
HN 7.26 0.27 3.04 0.16 0.90 0.05 19.8 1.0 28.0 1.4 132 10 46 1 0.48 0.04 147 2
Stage 1 (23) (23) (23) (22) (22) (5) (23) (23) (23)
HN 6.17 0.25a 19.0 0.13a 0.51 0.03a 14.5 0.8a 21.5 l.9a Ill 6 44 1 0.55 0.03 144 1
Stage 2 (28) (27) (28) (28) (18) (6) (28) (28) (27)
Number of animals used to determine each mean value are indicated in parentheses.
a Significantly different from control and HN Stage 1 at P < 0.05.
"Colloid osmotic pressure in the efferent arteriole was determined by dividing the COP in the afferent arteriole (COP plasma) by (I-filtration
fraction).
Abbreviations are: HMW, molecular weight > albumin; COP, colloid Osmotic pressure.
Table 5. Kidney tissue composition in early Heymann nephritis
KW (wet)
g KW (wet)/BW
KW (dry)
g
% H2O
content
Na content
Eq/g KW (dry)
K content
Eq/g KW (dry)
Control 1.52 0.09 0.0073 0.0002 0.336 0.015 78.0 0.4 283 13 279 4
(6)
HN Stage 1 1.53 0.07 0.0077 0.0004 0.332 0.009 78.2 0.5 292 13 292 9
(7)
HN Stage 2 2.20 0.08a 0.0101 0.0005a 0.428 0.0l1 80.5 0.4 379 20 308 7b
(10)
The K content of the kidney was corrected for K due to the residual blood remaining in the kidney [23].
Values for the ratio of kidney wet wt to body wt for all animals (including those for which no other values are given) in control (N = 29), HN
Stages 1 (N = 30) and 2 (N = 38) were 0.0074 0.0001, 0.0075 0.0002, and 0.0105 0.0004, respectively.
a The value is significantly different from control and HN Stage 1 at P < 0.05.
b The value is significantly different from control at P < 0.05.
Abbreviations: KW, kidney weight; BW, body weight.
It is possible that the depression in proximal tubule fluid
reabsorption we have observed in an early stage of Heymann
nephritis could have resulted from changes in peritubular
physical factors rather than immunologically mediated damage
to the luminal membrane of the proximal tubule. Acute depres-
sion of colloid osmotic pressure in the efferent arteriole has
been shown to decrease fractional proximal tubule fluid reab-
sorption in normal rats [36, 37]. Although colloid osmotic
pressure in the efferent arteriole was decreased in stage 2, it is
known that chronic depression in colloid osmotic pressure in
the peritubular capillary does not always lead to decreased
fractional proximal tubule fluid reabsorption [33, 38, 39]. In a
recent review, Knox [40] presented evidence that hydrostatic
and oncotic pressures in the peritubular microcirculation may
not affect proximal tubule reabsorption in all situations. There-
fore, one cannot assume that decreased colloid osmotic pres-
sure in the peritubular capillary is entirely responsible for the
decrease in proximal tubule reabsorption of fluid and glucose.
Antibody mediated damage to the brush border in stage 2 of
Heymann nephritis and loss of reabsorptive surface may be the
important factor.
In stage 1 of Heymann nephritis, glucose reabsorption ap-
peared to be decreased in the first portion of the proximal
convoluted tubule, although overall reabsorption was similar to
that observed in normal animals. Small amounts of IgG are
normally filtered and IgG is identified easily in normal rat urine
[411. As stage 1 of Heymann nephritis is a period when antibody
to the brush border is increasing, it is possible that antibody
gains access to the tubule fluid in sufficient quantity to produce
a subtle functional effect with no readily demonstrable morpho-
logical counterpart.
Proximal tubule organic anion secretion was also depressed
in stage 2 of Heymann nephritis. The extraction ratio and
clearance of PAH were significantly less than that observed in
stage 1. The tubular handling of an organic cation (TEA) was
not similarly depressed. Application of the kidney slice tech-
nique to the study of organic ion transport in Heymann
nephritis has also revealed a dissociation of anion and cation
transport (unpublished observation). As a result of the tissue
slice experiments, it has been proposed that the organic anion
carrier in the basolateral membrane may sustain specific
antibody-mediated alteration. That mechanism could account
for the defect in PAH transport described here.
The alterations we have observed in renal hemodynamics
early in Heymann nephritis are somewhat different from the
changes described by others to occur late in the course of the
disease (stage 4 and beyond) [9, 10]. Whole kidney GFR
appears to be depressed throughout the course of the disease [9,
10]. Our results indicate that a decrease in SNGFR could
account for the decrease in whole kidney GFR that is seen early
in stage 2 of Heymann nephritis. In contrast, mean SNGFR was
found not to be decreased late in Heymann nephntis [9, 10] and
this finding prompted Allison, Wilson and Gottschalk [9] to
conclude that the decreased whole kidney GFR of late
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Heymann nephritis resulted from nephron loss. Two popula-
tions of nephrons were observed in this same study. One group
was characterized by large, dilated, pale proximal tubules and
the other group by small and atrophic tubules. In addition, the
remaining functional nephrons displayed greater variability in
SNGFR. The same heterogeneity of SNGFR was subsequently
observed by Ichikawa et a! [101 as well. In the latter study,
nephrons with a low filtration rate were found to have dimin-
ished plasma flow (QA) and a low ultrafiltration (Kf) coefficient.
Both parameters are determinants of SNGFR and their parallel
decrease could be attributable to a single factor, variable
occlusion of capillary loops [10]. The late chronic phase of
Heymann nephritis has also been described to be characterized
by variability in the accumulation of immunoglobulin and C3 in
individual glomeruli [10]. In our studies of stage 2, we have
observed uniform and homogeneous depression of SNGFR;
immunofluorescence microscopy also revealed no marked vari-
ation in the extent of deposition of immunoglobulin and C3 in
individual glomeruli. The decrease in whole kidney GFR in
stage 2 of Heymann nephritis was accompanied by a propor-
tional decrease in RPF and resulted in maintenance of a normal
filtration fraction. This association indicates that preglomerular
renal vasoconstriction could account for the reduction in GFR
in stage 2 of Heymann nephritis. In contrast, decrease of whole
kidney GFR late in Heymann nephritis was accompanied by
little change in RPF and resulted in substantial reduction in
filtration fraction [9].
The increased permeability of the glomerular capillary in
stage 2 of Heymann nephritis was manifested by a large rise in
urinary protein excretion. The increase in proteinuria was
characterized by an increase in the fractional and absolute
albumin excretion. The sieving coefficient for albumin in stage
2 was 30% lower than the value estimated in late Heymann
nephritis (stage 4 and beyond) [8]. This finding is not surprising
when one considers that the magnitude of proteinuria increases
progressively throughout stage 2, but remains relatively con-
stant in later states of disease [6]. It is not yet clear how possible
alterations in charge and/or size selectivity may contribute to
the increased filtration of albumin in Heymann nephritis
[42—44].
The marked increase in kidney mass noted in stage 2 may be
characteristic of kidneys with chronic renal damage. Kramp et
al [45] reported that selective necrosis in rat proximal tubules
by nephrotoxic agents resulted in significant increases in wet
and dry wt and water content of the kidney. Those findings
were considered to be consistent with the hyperplastic growth
of renal tissue. Similar changes in kidney tissue were observed
in stage 2 of Heymann nephritis and could also be the conse-
quence of hyperplasia. The increases in sodium and potassium
content of the kidney (30 and 10%, respectively) may also be
related to kidney growth in stage 2 of Heymann nephritis,
although it is not known which anatomical regions of the kidney
might have increased in size. In chronically diseased kidneys,
tubule growth is presumed to occur predominately in the
proximal segments [46]. However, tubular growth may occur
equally in proximal and distal segments of the remaining
nephrons after unilateral nephrectomy [47]. Hypertrophy of
distal tubules has been described late in Heymann nephritis [8],
but not in the early stages of the disease. Careful morphometric
studies are needed to identify the predominant loci of kidney
growth in stage 2 of Heymann nephritis.
We have described some features of kidney pathophysiology
in an early stage of Heymann nephritis that have not been
described to occur in chronic stages of the disease. These
abnormalities include impaired proximal tubule function and
uniform depression of SNGFR in superficial nephrons. It
should be noted that the reduction in proximal tubule function
was not as severe as might have been expected from the
extensive changes in the morphology of this segment. This may
be explained by the reserve capacity of the proximal tubules.
Distal nephron compensation would also contribute to an
overall kidney response that is compatible with survival. The
return to normal fractional proximal tubule fluid reabsorption
seen in late stages of Heymann nephritis [9, 10] may result from
partial restoration of the normal architecture of the tubule
epithelium that occurs later [6]. The degree to which recovery
of other proximal tubule functions may occur is unknown at
present. The details and time course of the transition to chronic
Heymann nephritis with nephron loss and variability of SNGFR
in remaining nephrons are also important areas for future
investigation.
Protein excretion of similar magnitude to that measured in
Heymann nephritis has also been observed in moderate chronic
serum sickness [12]. However, proteinuria in moderate chronic
serum sickness was not accompanied by alterations in either
proximal tubule morphology or function [12]. The demonstra-
tion of proximal tubule, as well as glomerular, impairment in
Heymann nephritis suggests that this is a unique animal model
of kidney disease. Not only may Heymann nephritis be used to
understand the alterations in glomerular function that accom-
pany human membranous nephropathy, but it may also increase
our appreciation of possible alterations in tubule function
associated with membranous nephritis [48] or other renal dis-
eases. Our experience with this model makes it clear that tubule
dysfunction may be difficult to identify and can be overlooked
when it occurs in the context of a severe glomerular lesion.
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